More than a year after its promised deadline to investors, drugmaker puts alarming results in federal government's "virtual ...

NEW YORK, N.Y. – Pfizer Inc. on Monday released detailed analyses of myocarditis cases linked to its COVID-19 vaccine, ...

In a large-scale trial, modRNA was significantly better at preventing confirmed flu cases than a typical seasonal flu shot.

Pfizer’s mRNA flu vaccine outperformed the standard flu shot in a Phase 3 clinical trial, according to results published ...

Pfizer has released the full data from its phase 3 trial of an mRNA flu vaccine candidate, with the potential new shot demonstrating 34.5% greater efficacy compared to a control vaccine. | Pfizer has ...

Pfizer's mRNA flu vaccine worked better than a standard flu shot in a large Phase 3 trial, researchers reported.

Kansas Attorney General Kris Kobach announces he is suing Pfizer during a June 17, 2024, news conference at the Statehouse in Topeka. (Sherman Smith/Kansas Reflector) TOPEKA — Attorney General Kris ...

Vaccine maker Pfizer said Friday that trials of its vaccine in children ages 2 to 5 show that it did not provide the expected immunity in kids this age, and it is adding a third dose to the regimen.

The vaccine needs to be stored at around -70 degrees Celsius. Early data revealed Monday that Pfizer's COVID-19 vaccine candidate could be up to 90% effective. The company still needs to submit its ...